CARE reaffirms rating of Cipla’s bank facilities

01 Mar 2013 Evaluate

Credit rating agency, CARE has reaffirmed ‘AAA’ rating to Cipla’s long-term bank facilities worth Rs 72.38 crore which was enhanced from 68.60 crore and ‘A1+’ rating to company’s short-term bank facilities  worth Rs 1,723.50 crore.

The company has received the said rating on the back of its leading market position in respiratory segment, stable business performance, continuing strong financial profile characterized by low gearing levels and a healthy liquidity position.

Cipla focuses on development of new formulations and has a wide range of pharmaceutical products. It offers prescription drugs, bulk drugs, animal products and pesticides. It also offers a wide range of food and beverages, baked foods, oral hygiene products, detergents, room fresheners and personal care products.

Cipla Share Price

1497.45 -23.10 (-1.52%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×